Christian B. Voigtlander Sells 1,962 Shares of ICU Medical, Inc. (NASDAQ:ICUI) Stock

ICU Medical, Inc. (NASDAQ:ICUI) COO Christian B. Voigtlander sold 1,962 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $169.08, for a total value of $331,734.96. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

ICU Medical Stock Down 6.0 %

Shares of ICUI stock traded down $10.06 during mid-day trading on Tuesday, hitting $157.75. The stock had a trading volume of 383,721 shares, compared to its average volume of 274,687. ICU Medical, Inc. has a 12-month low of $83.26 and a 12-month high of $196.26. The firm has a market capitalization of $3.86 billion, a P/E ratio of -34.68 and a beta of 0.66. The firm’s 50-day moving average is $175.98 and its two-hundred day moving average is $146.15. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Raymond James raised their target price on ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. KeyCorp boosted their price target on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a report on Wednesday, November 13th. Finally, Jefferies Financial Group began coverage on ICU Medical in a report on Monday, October 14th. They issued a “hold” rating and a $183.00 price target on the stock. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $173.00.

Institutional Investors Weigh In On ICU Medical

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ICUI. Hexagon Capital Partners LLC increased its holdings in shares of ICU Medical by 162.7% in the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock valued at $36,000 after purchasing an additional 122 shares during the period. Allworth Financial LP grew its holdings in ICU Medical by 100.0% during the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 100 shares during the period. Innealta Capital LLC acquired a new stake in ICU Medical during the second quarter worth about $32,000. Venturi Wealth Management LLC grew its holdings in ICU Medical by 1,510.0% during the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock worth $59,000 after acquiring an additional 302 shares during the period. Finally, Point72 Hong Kong Ltd acquired a new stake in ICU Medical during the third quarter worth about $72,000. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.